Harvest Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Harvest Management’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-70,000	Closed	-$1.62M	–	83
2020 Q4	$1.62M	Buy	+70,000	New	+$887K	1.32%	19

Harvest Management's PRVL Position: Q1 2021 in Review

Harvest Management sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 70,000 shares — an estimated $1.62M sold.

Harvest Management first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $1.62M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

Harvest Management reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Harvest Management sold 70,000 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $1.62M.
Harvest Management first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Harvest Management's Prevail Therapeutics Inc. Common Stock position peaked at $1.62M in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Harvest Management's 13F filing for Q1 2021, filed 4 May 2021.